WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that its Chief Operating Officer, Thomas A. Keuer, will present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place September 8-10, 2015 in New York City.
Help employers find you! Check out all the jobs and post your resume.
